#UHC removes considerable barriers to access to care but does not necessarily imply an absence of barriers.
Socioeconomic status (#SES) is known to influence access to 🫀 care for children & adults with #PCHD/#CHD/#ACHD, requiring 🤝 action.
Our review: https://t.co/kEiG7kmbXZ
Very excited to share the latest paper from our lab from @JordanSFChan@aa_greenwell (the first 1st author original research paper for Jordan) where we further explored the actions of #liraglutide (GLP-1R Agonist) in experimental #diabetic_cardiomyopathy.
https://t.co/8Vk8TnMgUf
As tomorrow is the start of the holiday long weekend for us in #Canada, I thought I’d actually share some exciting news a tad bit early that starting tomorrow, July 01, I will officially be #FullProfessor@UAlberta@UAlberta_Pharm
Ok papers really do appear faster online now than in the past. Once again had no idea this was online already a week ago, but very excited to share our latest review focusing on models of diabetic heart disease.
https://t.co/Fczf0mMDLr
Didn’t realize it came online this Monday, but very happy to share the latest exciting research from the very talented @aa_greenwell just published in @AJPEndoMetab
https://t.co/LrRe6Nvymg
Really excited that our new perspective on incretin-based therapies and their potential mechanisms of action with relation to CV biology is now online https://t.co/QqcxDvFdr4
Feeling very honoured to have received a #VanierCanada Scholarship. Thank you to @CIHR_IRSC for this wonderful opportunity, and to my colleagues and supervisor @JussherLab for all the incredible support and guidance. Looking forward to the next three years!